Some research on large pharma margins: https://jamanetwork.com/journals/jama/article-abstract/2762308, summary is...
The median gross profit margin was 76.5% (95% CI, 70.3%-82.7%), the median EBITDA margin was 29.4% (95% CI, 26.3%-32.5%), and the median net income margin was 13.8% (95% CI, 10.2%-17.4%).
So my read is that manufacturing (COGS) is around 23.5%, and adding operations takes costs to about 70.6%. If MSB can command a 30% royalty for no effort other than patent upkeep that looks pretty good to me. My take on MSB's strategy is to take on manufacturing & distribution only where it is fairly low-risk - pretty much where there is a small and well-defined set of customers. Like pediatric aGVHD where half the potential USA patients are treated at a few dozen centres.
Sooner or later MSB will probably want to "own" the manufacturing & distribution for selective treatments, but I can't see them trying to build a salesforce for USA COVID ARDS due to far too many customers to cover, too much risk to ramp up so quickly. Much more likely to work with a pharma partner that already services ICUs across the country.
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
Some research on large pharma margins:...
-
-
- There are more pages in this discussion • 16,036 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 43578 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 31763 | 1.100 |
2 | 33264 | 1.090 |
2 | 18897 | 1.085 |
2 | 18926 | 1.080 |
1 | 18000 | 1.075 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 23400 | 3 |
1.135 | 1090 | 1 |
1.140 | 65000 | 4 |
1.145 | 64500 | 3 |
1.150 | 92314 | 9 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |